Shanghai Model Organisms Center, Inc. (SHA:688265)
49.03
+0.82 (1.70%)
Jan 23, 2026, 3:00 PM CST
SHA:688265 Revenue
Shanghai Model Organisms Center had revenue of 106.94M CNY in the quarter ending September 30, 2025, with 21.52% growth. This brings the company's revenue in the last twelve months to 419.09M, up 15.32% year-over-year. In the year 2024, Shanghai Model Organisms Center had annual revenue of 381.24M with 4.01% growth.
Revenue (ttm)
419.09M
Revenue Growth
+15.32%
P/S Ratio
8.85
Revenue / Employee
573.31K
Employees
731
Market Cap
3.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 381.24M | 14.69M | 4.01% |
| Dec 31, 2023 | 366.55M | 63.58M | 20.99% |
| Dec 31, 2022 | 302.97M | 27.70M | 10.06% |
| Dec 31, 2021 | 275.27M | 79.08M | 40.31% |
| Dec 31, 2020 | 196.19M | 41.39M | 26.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.69B |
| Qingdao Vland Biotech INC. | 1.39B |
| Beijing Kawin Technology Share-Holding | 1.15B |
| Guangdong VTR Bio-Tech | 830.87M |
| Boji Medical Technology | 770.19M |
| Cabio Biotech (Wuhan) | 596.47M |
| Yantai Zhenghai Biotechnology | 347.60M |
| Shanghai Shen Lian Biomedical | 292.81M |